Skip to main content
. 2021 Mar 31;26(6):414–424. doi: 10.1159/000514085

Table 3.

Comparisons of the different treatment groups with the arm CI in group RCI as reference

Evolution from baseline*
Difference versus RCI arm CI*
mean 95% CI mean 95% CI p value
EUROQOL EQ-5D
 Abstention 6.33 (−4.75; 17.40) 0.54 (−14.10; 15.18) 0.94
 CROS 2.42 (−2.84; 7.69) −3.36 (−14.66; 7.94) 0.56
 BAHS 3.87 (−12.05; 19.78) −1.92 (−20.64; 16.80) 0.84
 RCI arm “observation” 1.62 (−3.89; 7.13) −4.17 (−15.53; 7.20) 0.47
 RCI arm CI 5.79 (−4.05; 15.63)
EQ-5D VAS
 Abstention 4.67 (−4.21; 13.54) −7.05 (−18.47; 4.38) 0.23
 CROS −0.98 (−5.22; 3.26) 12.70 (20.91;4.48) 0.003
 BAHS 4.77 (−2.85; 12.39) −6.95 (−17.07; 3.17) 0.18
 RCI arm “observation” 0.46 (−4.20; 5.12) 11.26 (19.81;2.70) 0.01
 RCI arm CI 11.72 (4.70; 18.73)
NCIQ
 Abstention 1.9 (−8.0; 11.8) 13.29 (25.08;1.49) 0.03
 CROS 7.7 (4.5; 10.8) 7.51 (14.62;0.41) 0.04
 BAHS 14.3 (7.9; 20.7) −0.87 (−9.89; 8.15) 0.85
 RCI arm “observation” 2.6 (−2.9; 8.1) 12.57 (21.00;4.14) 0.004
 RCI arm CI 15.2 (8.8; 21.6)
VAS tinnitus severity
 Abstention −8.6 (−26.1; 8.9) 17.17 (−3.33; 37.68) 0.10
 CROS 8.9 (14.5;3.4) 16.85 (5.10; 28.60) 0.005
 BAHS 23.4 (35.8;11.1) 2.35 (−13.87; 18.57) 0.78
 RCI arm “observation” −4.3 (−14.0; 5.4) 21.48 (7.19; 35.77) 0.004
 RCI arm CI 25.8 (36.2;15.4)
SNR50 SpeNbe (dB)
 Abstention −2.03 (−5.66; 1.61) 3.47 (−1.29; 8.22) 0.15
 CROS 6.43 (9.00;3.85) −0.93 (−4.62; 2.75) 0.62
 BAHS −1.25 (−8.49; 5.98) 4.24 (−3.09; 11.57) 0.26
 RCI arm “observation” 3.27 (5.95;0.59) 2.22 (−1.83; 6.28) 0.28
 RCI arm CI 5.49 (8.51;2.47)
SNR50 S0N0 (dB)
 Abstention −6.04 (−16.57; 4.50) −3.00 (−13.87; 7.87) 0.59
 CROS 1.80 (3.02;0.58) 1.23 (−1.36; 3.83) 0.35
 BAHS 0.95 (−3.96; 5.85) 3.98 (−1.47; 9.44) 0.15
 RCI arm “observation” 1.99 (3.04;0.94) 1.04 (−1.60; 3.68) 0.44
 RCI arm CI 3.04 (5.46; −0.61)
SNR50 SbeNpe (dB)
 Abstention −0.02 (−2.66; 2.61) 2.94 (−0.39; 6.27) 0.08
 CROS −0.34 (−1.71; 1.03) 2.62 (0.16; 5.09) 0.04
 BAHS 0.79 (−6.07; 7.65) 3.75 (−3.61; 11.12) 0.32
 RCI arm “observation” 2.97 (5.28;0.67) −0.01 (−3.05; 3.03) 1.00
 RCI arm CI 2.96 (4.95;0.97)
Horizontal localization − RMSE (°)
 Abstention −2.66 (−18.92; 13.60) 6.17 (−12.44; 24.79) 0.51
 CROS 7.72 (2.71; 12.73) 16.56 (6.12; 27.00) 0.002
 BAHS −10.10 (−20.24; 0.04) −1.27 (−14.84; 12.31) 0.85
 RCI arm “observation” 9.58 (18.44;0.72) −0.75 (−13.40; 11.91) 0.91
 RCI arm CI −8.84 (−17.94; 0.27)

SpeNbe, speech presented to the poor ear and noise to the better ear; SbeNpe, noise presented to the poor ear and speech to the better ear; 95 CI, 95% confidence interval; BAHS, bone-anchored hearing system; CI, cochlear implant; EQ-5D, EuroQoL-5D; NCIQ, Nijmegen Cochlear implant Questionnaire; VAS, Visual Analogue Scale; CROS, contralateral routing of the signal; RCI, randomized for CI; SNR50, signal-to-noise ratio for 50% correct word recognition; S0N0, speech and noise collocated and presented from the loudspeaker in front of the subject; RMSE, root mean square error.

*

Mean differences, 95% CIs, and p values are estimated using linear regressions adjusted for the baseline value of the outcome, with a robust estimator of variance. Significant differences are indicated in bold.